Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intensive Chemotherapy Combined With Early, Adequate, and Intensive Use of Rituximab for Aggressive B-NHL in Children and Adolescents

NCT07168980 is registered in ClinicalTrials.gov with Children's Cancer Group, China as lead sponsor.

NCT NCT07168980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07168980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intensive Chemotherapy Combined With Early, Adequate, and Intensive Use of Rituximab for Aggressive B-NHL in Children and Adolescents
Lead sponsor
Children's Cancer Group, China
Phase
Phase 2/3
Overall status
Recruiting
Start date
July 1, 2025
Completion date
June 30, 2030
Enrollment
87 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mature b-cell non-hodgkin lymphoma